RN

Rameshwar Nivrutti Kendhale

Active Director Director DIN 10617400
DIN 10617400 First appointment May 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Rameshwar Nivrutti Kendhale

Data last updated:

Rameshwar Nivrutti Kendhale is a Director at Rx.Biozenic Pharma Private Limited (since 2024).

DIN 10617400
Primary Designation Director
First Appointment 04 May 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rx.Biozenic Pharma Private Limited U47721MH2024PTC424692
Director04 May 20242024Active

Board colleagues of Rameshwar Nivrutti Kendhale

NameDINCompanyDesignation
Krishna Ramkisan Tupe10617399Rx.Biozenic Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Rx.Biozenic Pharma Private Limited
Premium access

Shareholding and investment profile for Rameshwar Nivrutti Kendhale

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rameshwar Nivrutti Kendhale

Rameshwar Nivrutti Kendhale currently holds 1 directorship: Rx.Biozenic Pharma Private Limited (Director, since 04 May 2024).

Rameshwar Nivrutti Kendhale was first appointed on 04 May 2024 as Director at Rx.Biozenic Pharma Private Limited.

The current boards of Rameshwar Nivrutti Kendhale's companies include Krishna Ramkisan Tupe (Rx.Biozenic Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available